Evidence map›Paper›PMID 27325774›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Multiple layers of transcriptional regulation by PLZF in NKT-cell development.

Ai-Ping Mao, Michael G Constantinides, Rebecca Mathew, Zhixiang Zuo, Xiaoting Chen, Matthew T Weirauch, Albert Bendelac

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 107 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Primordial Cells Bridging the Gap Between Innate and Adaptive Immunity.Advances in experimental medicine and biology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Invariant natural killer T cells in lung diseases.Experimental & molecular medicine · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ai-Ping MaoCommittee on Immunology, University of Chicago, Chicago, IL 60637; Department of Pathology, University of Chicago, Chicago, IL 60637;
Michael G ConstantinidesCommittee on Immunology, University of Chicago, Chicago, IL 60637; Department of Pathology, University of Chicago, Chicago, IL 60637;
Rebecca MathewCommittee on Immunology, University of Chicago, Chicago, IL 60637; Department of Pathology, University of Chicago, Chicago, IL 60637;
Zhixiang ZuoState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China;
Xiaoting ChenCenter for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Matthew T WeirauchCenter for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Albert BendelacCommittee on Immunology, University of Chicago, Chicago, IL 60637; Department of Pathology, University of Chicago, Chicago, IL 60637; abendela@bsd.uchicago.edu.
University of Chicago · USCincinnati Children's Hospital Medical Center · USSun Yat-sen University · CN

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI LIU, CAMBRIAN YANGSHAO · 1990 to 2025
$29.8M
Transcriptional Regulation of Innate-Like T CellsR01AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI ESTERHAZY, DARIA · 1996 to 2025
$7.6M
Transcriptional Regulation of Innate-Like T CellsR37AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2017 to 2023
$3.4M
A common hematopoietic precursor to innate lymphoid cellsR01AI108643 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2014 to 2017
$1.5M
Allergic inflammation in genetic models of lung ILC2 deficiencyR01HL118092 · NHLBI · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2013 to 2016
$1.5M
NHLBI NIH HHS R01 HL118092NIAID NIH HHS R01 AI038339NIAID NIH HHS R01 AI108643NIAID NIH HHS R37 AI038339NIDDK NIH HHS P30 DK042086
6 · The paper itself

Abstract

The transcription factor PLZF [promyelocytic leukemia zinc finger, encoded by zinc finger BTB domain containing 16 (Zbtb16)] is induced during the development of innate and innate-like lymphocytes to direct their acquisition of a T-helper effector program, but the molecular mechanisms involved are poorly understood. Using biotinylation-based ChIP-seq and microarray analysis of both natural killer T (NKT) cells and PLZF-transgenic thymocytes, we identified several layers of regulation of the innate-like NKT effector program. First, PLZF bound and regulated genes encoding cytokine receptors as well as homing and adhesion receptors; second, PLZF bound and activated T-helper-specific transcription factor genes that in turn control T-helper-specific programs; finally, PLZF bound and suppressed the transcription of Bach2, a potent general repressor of effector differentiation in naive T cells. These findings reveal the multilayered architecture of the transcriptional program recruited by PLZF and elucidate how a single transcription factor can drive the developmental acquisition of a broad effector program.

Indexed as

Gene Expression RegulationAnimalsBasic-Leucine Zipper Transcription FactorsCore Binding Factor alpha SubunitsCytokinesKruppel-Like Transcription FactorsMice, Inbred C57BLMice, TransgenicNatural Killer T-CellsPromyelocytic Leukemia Zinc Finger ProteinProto-Oncogene Proteins c-etsReceptors, ChemokineT-Lymphocytes, Helper-InducerBach2 protein, mouseBasic-Leucine Zipper Transcription FactorsCore Binding Factor alpha SubunitsCytokinesKruppel-Like Transcription FactorsPromyelocytic Leukemia Zinc Finger ProteinProto-Oncogene Proteins c-etsReceptors, ChemokineZbtb16 protein, mousedevelopmentlymphocyteNKTPLZF

Identifiers

PMID27325774
PMCPMC4941452
OpenAlexW2461304145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.